Altimmune, Inc.
February 26, 2024 - by Joey Ramson
$ALT is up today in reaction to a clinical trial update from rival Zealand Pharma ($ZLDPF). A couple of weeks ago $ALT was criticized in a short seller report released by Kerrisdale Capital.
